Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.
about
SPRINT: The Study Nephrologists Might Take With a Grain of SaltFrom ARB to ARNI in Cardiovascular ControlNovel Approaches to Investigate One-Carbon Metabolism and Related B-Vitamins in Blood PressureFree versus Fixed Combination Antihypertensive Therapy for Essential Arterial Hypertension: A Systematic Review and Meta-AnalysisThe Hypertension Pandemic: An Evolutionary Perspective.Prevention of stroke: a strategic global imperative.Diagnosing and Managing Primary Aldosteronism in Hypertensive Patients: a Case-Based Approach.Short-term hypertension management in community is associated with long-term risk of stroke and total death in China: A community controlled trialRandomized multicentre pilot study of sacubitril/valsartan versus irbesartan in patients with chronic kidney disease: United Kingdom Heart and Renal Protection (HARP)- III-rationale, trial design and baseline data.Graphics and Statistics for Cardiology: Data visualisation for meta-analysis.Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition ExamiStroke patients and their attitudes toward mHealth monitoring to support blood pressure control and medication adherence.A practical approach to the pharmacological management of hypertension in older people.Declining blood pressure and intensification of blood pressure management among people over 80 years: cohort study using electronic health records.Salidroside contributes to reducing blood pressure and alleviating cerebrovascular contractile activity in diabetic Goto-Kakizaki Rats by inhibition of L-type calcium channel in smooth muscle cellsEvaluation of the chronic disease management program for appropriateness of medication adherence and persistence in hypertension and type-2 diabetes patients in Korea.The impact of antihypertensives on kidney disease.Kinetics of Hypotension during 50 Sessions of Resistance and Aerobic Training in Hypertensive Patients: a Randomized Clinical TrialTotal antihypertensive therapeutic intensity score and its relationship to blood pressure reduction.The 2017 Focused Update of the Guidelines of the Taiwan Society of Cardiology (TSOC) and the Taiwan Hypertension Society (THS) for the Management of HypertensionGender differences in hypertension awareness, antihypertensive use and blood pressure control in Bangladeshi adults: findings from a national cross-sectional surveyThe effects of alpha 1-adrenoceptor blockade and angiotensin converting enzyme inhibition on central and brachial blood pressure and vascular reactivity: the doxazosin-ramipril study.Blood Pressure Management for Stroke Prevention and in Acute StrokeHigh normotension is associated with future metabolic syndrome but not cardiovascular disease: A 10-year longitudinal study.Effects of Baicalin on Blood Pressure and Left Ventricular Remodeling in Rats with Renovascular HypertensionImpact of adverse drug events and treatment satisfaction on patient adherence with antihypertensive medication - a study in ambulatory patients.Improvement in Retinal Capillary Rarefaction After Valsartan Treatment in Hypertensive Patients.Therapeutic Benefits of l-Arginine: An Umbrella Review of Meta-analyses.Comparative effectiveness of fourth-line anti-hypertensive agents in resistant hypertension: A systematic review and meta-analysis.Are home visits an effective method for diabetes management? A quantitative systematic review and meta-analysis.Visit-to-Visit Systolic Blood Pressure Variability and Cardiovascular Outcomes: New Data From a Real-World Korean Population.Longitudinal Trends in Hypertension Management and Mortality Among Octogenarians: Prospective Cohort StudyControlling Hypertension to Prevent Target Organ Damage: Perspectives from the World Hypertension League President.Blood pressure and complications in individuals with type 2 diabetes and no previous cardiovascular disease: national population based cohort study.Prevalence of Eligibility Criteria for the Systolic Blood Pressure Intervention Trial in US Adults Among Excluded Groups: Age <50 Years, Diabetes Mellitus, or a History of StrokeHypertension Canada's 2016 Canadian Hypertension Education Program guidelines for pharmacists: An updateRelative Contributions of Arterial Stiffness and Hypertension to Cardiovascular Disease: The Framingham Heart Study.Diabetes and Cause-Specific Mortality in Mexico City.Blood pressure control in type 2 diabetic patients.Evidence for Reverse Causality in the Association Between Blood Pressure and Cardiovascular Risk in Patients With Chronic Kidney Disease.
P2860
Q26745888-16D9BEE8-EF6B-48C9-AB9C-BBF7E1098CC3Q28073372-48EA2706-1673-4AAA-B34A-411686473429Q28074234-4CCFECA8-FC2A-4E4C-A3A3-EF7A0A029C54Q28553625-DEEA7E26-33DC-462F-84BD-B1DE048B0CE1Q30235938-E38DD542-78A0-4455-A174-E2CB7E83D676Q30248840-BCAC9123-C1F8-4800-8ACA-D16CF82238B6Q30276057-0C462EDD-2ABC-4E66-B2E0-3C92658009F1Q30830649-BF3FC7D5-3B22-4D2C-BACA-C4847E8FD9B9Q31131772-ED7E782C-EE1E-4D31-BCC7-C75445C10D50Q31140814-CA316223-0044-44D0-96F7-55C95FCF84FCQ33168252-E1BF0559-3159-4AD7-B7E4-E31F1F8E1714Q33449397-DF898E4C-DF45-4968-B825-3A98BB877AC4Q33572617-83D2EC7F-AA4E-466D-8351-6BF01062F240Q33601424-C0F1DC40-C54F-4F8E-BACB-37200CBB3D0AQ33604575-69487203-ED48-4098-BE88-EB3D933B5262Q33621412-1387BAFA-3655-4ABE-A5AE-B71D6C90627DQ33632021-98D4D497-60CC-4956-8FA9-FBA1BC5E3917Q33647431-FF8CAC32-6318-4312-B5F7-75D09CB5533AQ33668225-8D735210-E0B0-4A70-A4EB-2A9AAB8FA6DDQ33729817-3B3ECF41-46E9-4467-BA8F-DA8983E09253Q33731059-C8C39052-0A97-41B8-813E-3F5CD052E6B4Q33734090-11E48486-62C3-4021-8D79-F90325F878B9Q33783596-E785ABBC-EE5B-48F4-888C-DF85FEC9D545Q33833756-2CA7CA73-21AD-49F8-AF3A-853BA0557308Q33834911-E96D522D-EFC2-4F35-B1DB-2A8B0E8C2D21Q34555590-3DE7EC42-07B8-4B68-ACB4-5F06A5357403Q36053490-CDE52B89-D77E-40BA-9BEF-245DAE913A4DQ36142271-8208E2FB-F4B4-4C75-BD74-50044C149DB6Q36195791-8380C21D-9AE2-46A7-A7CA-67ACBFE650E2Q36256307-1C6CF36A-C3CE-466B-8CA2-B8E9A91C57A9Q36335504-49C350C8-E02C-4E74-9450-CBB9E1170A62Q36988076-B17053AC-4619-4EA5-B073-6930C5CD0630Q37103583-31F50EC9-9CDD-45BA-BBB3-A35877962667Q37154677-00155BAC-6747-4397-95C1-47189DD4843BQ37240728-287AF109-E6A0-4C5F-BF7B-3A47ACA25FF2Q37384476-20BCD77C-A67B-445F-BB90-AB1D8BC0FC58Q37556166-C5A2A025-ACC9-4E93-81BB-77BDCCCF89EBQ37559975-0BDFE833-E747-441C-8630-4C444CAAA1D7Q37566950-7A091EA7-B193-46DB-8A7A-2DA880339437Q37574305-5357B834-8254-4247-ABDF-566F0870CB42
P2860
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Blood pressure lowering for pr ...... atic review and meta-analysis.
@ast
Blood pressure lowering for pr ...... atic review and meta-analysis.
@en
Blood pressure lowering for pr ...... atic review and meta-analysis.
@nl
type
label
Blood pressure lowering for pr ...... atic review and meta-analysis.
@ast
Blood pressure lowering for pr ...... atic review and meta-analysis.
@en
Blood pressure lowering for pr ...... atic review and meta-analysis.
@nl
prefLabel
Blood pressure lowering for pr ...... atic review and meta-analysis.
@ast
Blood pressure lowering for pr ...... atic review and meta-analysis.
@en
Blood pressure lowering for pr ...... atic review and meta-analysis.
@nl
P2093
P50
P1433
P1476
Blood pressure lowering for pr ...... atic review and meta-analysis.
@en
P2093
Amit Kiran
Connor A Emdin
Dena Ettehad
P304
P356
10.1016/S0140-6736(15)01225-8
P407
P577
2015-12-23T00:00:00Z